Mural Oncology plc
Mural Oncology plc (MURA) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
mura · stock forecast · 2 analysts (3M) · FMP · updated Feb 3, 2026
Analyst Rating & Consensus
Based on 2 Wall Street analysts in the past 3 months
Buy
2 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $2.04
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $2.03 | ↓ 0.64% |
1-day model range: $2.02–$2.03. Peak: $2.03 (-0.64%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · MURA · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-03-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-25 | Jones Trading | Downgrade ↓ | Buy→Hold |
| 2025-03-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Mural Oncology plc (MURA) stock. Of the recent 5 rating actions, 0 were upgrades and 1 were downgrades. 2 analysts currently cover MURA.
Analyst Recommendation Trends
MURA analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 2 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$8M
↓ 63.2% YoY
Revenue Next Year
$10M
↑ 27.3% YoY
EPS This Year
$-5.66
EPS Next Year
$-0.39
↓ 93.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast MURA EPS of $-5.66 for the current fiscal year, based on estimates from 1 analysts. The MURA revenue forecast is $8M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The MURA stock forecast is supported by two independent data sources: analyst consensus ratings from 2 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus MURA price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The MURA short-term stock prediction for tomorrow is $2.03 (-0.64%).
Mural Oncology plc trades on NASDAQ under the ticker MURA. The MURA stock outlook for 2027 is broadly positive, supported by a Buy consensus among 50% of covering analysts.
Frequently asked questions
MURA forecast · 8 questionsAccording to 2 Wall Street analysts, the average 12-month MURA price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $2.04.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.